Literature DB >> 15999190

Multifunctional redox catalysts as selective enhancers of oxidative stress.

Fiona H Fry1, Andrea L Holme, Niroshini M Giles, Gregory I Giles, Catriona Collins, Kim Holt, Sandra Pariagh, Thomas Gelbrich, Michael B Hursthouse, Nick J Gutowski, Claus Jacob.   

Abstract

Certain cancer cells proliferate under conditions of oxidative stress (OS) and might therefore be selectively targeted by redox catalysts. Among these catalysts, compounds containing a chalcogen and a quinone redox centre are particularly well suited to respond to the presence of OS. These catalysts combine the specific electrochemical features of quinones and chalcogens. They exhibit high selectivity and efficiency against oxidatively stressed rat PC12, human Jurkat and human Daudi cells in cell culture, where their mode of action most likely involves the catalytic activation of existent and the generation of new reactive oxygen species. The high efficiency and selectivity shown by these catalysts makes them interesting for the development of anti-cancer drugs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15999190     DOI: 10.1039/b502197a

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  10 in total

1.  Synchrotron radiation induced X-ray emission studies of the antioxidant mechanism of the organoselenium drug ebselen.

Authors:  Jade B Aitken; Peter A Lay; T T Hong Duong; Roshanak Aran; Paul K Witting; Hugh H Harris; Barry Lai; Stefan Vogt; Gregory I Giles
Journal:  J Biol Inorg Chem       Date:  2012-02-11       Impact factor: 3.358

2.  DCPIP (2,6-dichlorophenolindophenol) as a genotype-directed redox chemotherapeutic targeting NQO1*2 breast carcinoma.

Authors:  Christopher M Cabello; Sarah D Lamore; Warner B Bair; Angela L Davis; Sara M Azimian; Georg T Wondrak
Journal:  Free Radic Res       Date:  2010-11-01

Review 3.  Implications of co-morbidity for etiology and treatment of neurodegenerative diseases with multifunctional neuroprotective-neurorescue drugs; ladostigil.

Authors:  Moussa B H Youdim; Tamar Amit; Orit Bar-Am; Orly Weinreb; Mara Yogev-Falach
Journal:  Neurotox Res       Date:  2006-12       Impact factor: 3.911

Review 4.  Redox-directed cancer therapeutics: molecular mechanisms and opportunities.

Authors:  Georg T Wondrak
Journal:  Antioxid Redox Signal       Date:  2009-12       Impact factor: 8.401

5.  Antimelanoma activity of the redox dye DCPIP (2,6-dichlorophenolindophenol) is antagonized by NQO1.

Authors:  Christopher M Cabello; Warner B Bair; Alexandra S Bause; Georg T Wondrak
Journal:  Biochem Pharmacol       Date:  2009-04-24       Impact factor: 5.858

6.  NQO1-activated phenothiazinium redox cyclers for the targeted bioreductive induction of cancer cell apoptosis.

Authors:  Georg T Wondrak
Journal:  Free Radic Biol Med       Date:  2007-04-10       Impact factor: 7.376

Review 7.  Menadione: a platform and a target to valuable compounds synthesis.

Authors:  Acácio S de Souza; Ruan Carlos B Ribeiro; Dora C S Costa; Fernanda P Pauli; David R Pinho; Matheus G de Moraes; Fernando de C da Silva; Luana da S M Forezi; Vitor F Ferreira
Journal:  Beilstein J Org Chem       Date:  2022-04-11       Impact factor: 2.544

8.  Novel Organoselenium Redox Modulators with Potential Anticancer, Antimicrobial, and Antioxidant Activities.

Authors:  Marwa Sak; Yasair S Al-Faiyz; Hany Elsawy; Saad Shaaban
Journal:  Antioxidants (Basel)       Date:  2022-06-23

Review 9.  Small Molecule Catalysts with Therapeutic Potential.

Authors:  Yannick Ney; Muhammad Jawad Nasim; Ammar Kharma; Lama A Youssef; Claus Jacob
Journal:  Molecules       Date:  2018-03-27       Impact factor: 4.411

10.  Anti-tubercular profile of new selenium-menadione conjugates against Mycobacterium tuberculosis H37Rv (ATCC 27294) strain and multidrug-resistant clinical isolates.

Authors:  Ruan C B Ribeiro; Daniel B de Marins; Iris Di Leo; Luana da Silva Gomes; Matheus G de Moraes; Bruno L Abbadi; Anne D Villela; Wellington F da Silva; Luiz Cláudio R P da Silva; Pablo Machado; Cristiano Valim Bizarro; Luiz Augusto Basso; Marcela Cristina de Moraes; Vitor F Ferreira; Fernando de C da Silva; Vanessa Nascimento
Journal:  Eur J Med Chem       Date:  2020-09-23       Impact factor: 6.514

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.